Noah Rudisill

Noah joined Health Advances in 2022 and is a member of the biopharma and oncology practices. Noah brings experience in competitive landscape and market assessments, opportunity prioritization, corporate and portfolio strategy, and revenue forecasting across the biopharma sector.

Noah graduated summa cum laude with a BS in Physiological Science from the University of California, Los Angeles.